{"filing":{"accession_number":"0001832511-26-000032","cik":"0001832511","ticker":"PIIIW","company_name":"P3 Health Partners Inc.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"piii-20260810.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/piii-20260810.htm"},"events":[{"id":26512,"run_id":24098,"accession_number":"0001832511-26-000032","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"P3 Health Partners announced its financial results for Q2 2026 and the six-month period ended June 30, 2026 via press release furnished as Exhibit 99.1. The disclosure includes key metrics (revenue of $386 million, net income of $15.7 million vs. prior-year loss of $43.7 million, adjusted EBITDA of $54.4 million), membership data, and revised full-year 2026 guidance raising adjusted EBITDA outlook. This is a standard quarterly earnings release under Item 2.02.","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27664,"accession_number":"0001832511-26-000032","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"P3 Health Partners announced its financial results for Q2 2026 and the six-month period ended June 30, 2026 via press release furnished as Exhibit 99.1. The disclosure includes key metrics (revenue of $386 million, net income of $15.7 million vs. prior-year loss of $43.7 million, adjusted EBITDA of $54.4 million), membership data, and revised full-year 2026 guidance raising adjusted EBITDA outlook. This is a standard quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:06:56.023233+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27664,"accession_number":"0001832511-26-000032","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"P3 Health Partners announced its financial results for Q2 2026 and the six-month period ended June 30, 2026 via press release furnished as Exhibit 99.1. The disclosure includes key metrics (revenue of $386 million, net income of $15.7 million vs. prior-year loss of $43.7 million, adjusted EBITDA of $54.4 million), membership data, and revised full-year 2026 guidance raising adjusted EBITDA outlook. This is a standard quarterly earnings release under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:06:56.023233+00:00","company_name":"P3 Health Partners Inc.","ticker":"PIIIW","filing_date":"2026-08-10"}]}